Low income vs Togo: Access to anti-retroviral drugs, female
Low income
85.2%
in 2024
Togo
96.0%
in 2024
Low income rank
13th
Togo rank
14th
Access to anti-retroviral drugs, female over time
- Low income
- Togo
How they compare
Togo currently reports 96.0% against 85.2% in Low income, a difference of 10.8%.
That makes Togo's figure about 1.1 times Low income's.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Togo ahead.
Low income ranks 13th and Togo ranks 14th of 19 groups.
Across the 3 decades both report, Low income averaged higher in 1 and Togo in 2.
Head to head by decade
| Decade | Low income | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.2% | 4.6% | 0.6% | Low income |
| 2010s | 46.8% | 51.6% | 4.8% | Togo |
| 2020s | 79.0% | 91.2% | 12.2% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Low income or Togo?
- Togo, at 96.0% against 85.2% in Low income as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Low income and Togo?
- 10.8%, with Togo ahead.
- How many years of comparable data are there for Low income and Togo?
- 25 years are reported by both, from 2000 to 2024.
- How do Low income and Togo rank globally for access to anti-retroviral drugs, female?
- Low income ranks 13th and Togo ranks 14th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.